Cargando…
Prenatal exposure to serotonin reuptake inhibitors: a case report
Two premature twins (33 weeks gestation) were born to a woman who had used paroxetine during pregnancy for an anxiety-depression disorder. They were admitted to the NICU, where they showed prolonged RDS, cardiovascular malformations, and facial dysmorphisms. Soon after birth, they also presented abn...
Autores principales: | Marsella, Maria, Ubaldini, Elisabetta, Solinas, Agostina, Guerrini, Pietro |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848060/ https://www.ncbi.nlm.nih.gov/pubmed/20302650 http://dx.doi.org/10.1186/1824-7288-36-27 |
Ejemplares similares
-
The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors—Is Pharmacogenetics the Key?
por: Daud, Aizati N. A., et al.
Publicado: (2016) -
Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
por: Compagner, Chad, et al.
Publicado: (2021) -
Prenatal Selective Serotonin Reuptake Inhibitor Exposure, Depression, and Brain Morphology in Middle Childhood: Results From the ABCD Study
por: Moreau, Allison L., et al.
Publicado: (2022) -
Onset of Transient Sadness Following the Concomitant Use of a Triptan and
Selective Serotonin Reuptake Inhibitor/Serotonin Norepinephrine Reuptake Inhibitors
Therapy: A Case Report
por: Meng, Yuki, et al.
Publicado: (2021) -
Clinical pharmacology of serotonin selective reuptake inhibitors /
por: Preskorn, Sheldon
Publicado: (1996)